Rubio-Godoy V - Search Results

1

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

Speiser DE, Liénard D, Rufer N, Rubio-Godoy V, Rimoldi D, Lejeune F, Krieg AM, Cerottini JC, Romero P. Speiser DE, et al. Among authors: rubio godoy v. J Clin Invest. 2005 Mar;115(3):739-46. doi: 10.1172/JCI23373. J Clin Invest. 2005. PMID: 15696196 Free PMC article. Clinical Trial.

2

Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity.

Valmori D, Scheibenbogen C, Dutoit V, Nagorsen D, Asemissen AM, Rubio-Godoy V, Rimoldi D, Guillaume P, Romero P, Schadendorf D, Lipp M, Dietrich PY, Thiel E, Cerottini JC, Liénard D, Keilholz U. Valmori D, et al. Cancer Res. 2002 Mar 15;62(6):1743-50. Cancer Res. 2002. PMID: 11912149

3

Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity.

Valmori D, Dutoit V, Schnuriger V, Quiquerez AL, Pittet MJ, Guillaume P, Rubio-Godoy V, Walker PR, Rimoldi D, Liénard D, Cerottini JC, Romero P, Dietrich PY. Valmori D, et al. J Immunol. 2002 Apr 15;168(8):4231-40. doi: 10.4049/jimmunol.168.8.4231. J Immunol. 2002. PMID: 11937585

4

Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.

Romero P, Valmori D, Pittet MJ, Zippelius A, Rimoldi D, Lévy F, Dutoit V, Ayyoub M, Rubio-Godoy V, Michielin O, Guillaume P, Batard P, Luescher IF, Lejeune F, Liénard D, Rufer N, Dietrich PY, Speiser DE, Cerottini JC. Romero P, et al. Among authors: rubio godoy v. Immunol Rev. 2002 Oct;188:81-96. doi: 10.1034/j.1600-065x.2002.18808.x. Immunol Rev. 2002. PMID: 12445283 Review.

5

Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells.

Pittet MJ, Rubio-Godoy V, Bioley G, Guillaume P, Batard P, Speiser D, Luescher I, Cerottini JC, Romero P, Zippelius A. Pittet MJ, et al. Among authors: rubio godoy v. J Immunol. 2003 Aug 15;171(4):1844-9. doi: 10.4049/jimmunol.171.4.1844. J Immunol. 2003. PMID: 12902485

6

Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance.

Zippelius A, Batard P, Rubio-Godoy V, Bioley G, Liénard D, Lejeune F, Rimoldi D, Guillaume P, Meidenbauer N, Mackensen A, Rufer N, Lubenow N, Speiser D, Cerottini JC, Romero P, Pittet MJ. Zippelius A, et al. Among authors: rubio godoy v. Cancer Res. 2004 Apr 15;64(8):2865-73. doi: 10.1158/0008-5472.can-03-3066. Cancer Res. 2004. PMID: 15087405

7

A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination.

Speiser DE, Baumgaertner P, Barbey C, Rubio-Godoy V, Moulin A, Corthesy P, Devevre E, Dietrich PY, Rimoldi D, Liénard D, Cerottini JC, Romero P, Rufer N. Speiser DE, et al. Among authors: rubio godoy v. J Immunol. 2006 Jul 15;177(2):1338-48. doi: 10.4049/jimmunol.177.2.1338. J Immunol. 2006. PMID: 16818795

8

IL-12 controls cytotoxicity of a novel subset of self-antigen-specific human CD28+ cytolytic T cells.

Barbey C, Baumgaertner P, Devevre E, Rubio-Godoy V, Derre L, Bricard G, Guillaume P, Luescher IF, Liénard D, Cerottini JC, Romero P, Rufer N, Speiser DE. Barbey C, et al. Among authors: rubio godoy v. J Immunol. 2007 Mar 15;178(6):3566-74. doi: 10.4049/jimmunol.178.6.3566. J Immunol. 2007. PMID: 17339453

9

Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanoma.

Valmori D, Dutoit V, Rubio-Godoy V, Chambaz C, Liénard D, Guillaume P, Romero P, Cerottini JC, Rimoldi D. Valmori D, et al. Cancer Res. 2001 Jan 15;61(2):509-12. Cancer Res. 2001. PMID: 11212242

10

CD8+ T-cell response to NY-ESO-1: relative antigenicity and in vitro immunogenicity of natural and analogue sequences.

Romero P, Dutoit V, Rubio-Godoy V, Liénard D, Speiser D, Guillaume P, Servis K, Rimoldi D, Cerottini JC, Valmori D. Romero P, et al. Clin Cancer Res. 2001 Mar;7(3 Suppl):766s-772s. Clin Cancer Res. 2001. PMID: 11300471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page